Riozen Pharmaceutical Private Limited
About Riozen Pharmaceutical Private Limited
Data last updated:
Riozen Pharmaceutical Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U74999AP2016PTC104381. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Smita Samal and Rajesh Kumar Patra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1 – 1 – 193 Mvp Colony Sector – 11&12 Indira Nagar Pedawaltair, Visakhapatnam, Andhra Pradesh, India – 530017.
As per the financials filed for FY 2024, the company reported a revenue of ₹47,039, a decline of 93% compared to the previous year. For the same year it recorded a net loss of ₹3.28 Lakh and EBITDA of -₹3.06 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 79% over three years and 69% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Riozen Pharmaceutical Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1 – 1 – 193 Mvp Colony Sector – 11&12 Indira Nagar Pedawaltair, Visakhapatnam, Andhra Pradesh, India – 530017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Riozen Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Riozen Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Riozen Pharmaceutical Private Limited, buy the company report.
Financials of Riozen Pharmaceutical Private Limited
FY 2024 filings availableRiozen Pharmaceutical Private Limited reported revenue of ₹47,039 (down 93% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 69% over five years, including a 93% fall in the latest year. EBITDA fell 730% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Riozen Pharmaceutical Private Limited, buy the company report.
Board of directors of Riozen Pharmaceutical Private Limited
Riozen Pharmaceutical has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Smita Samal | Director | 02 Nov 2016 | 9 Years 11 Months | Current |
| Rajesh Kumar Patra Also directs: Riocure Pharmaceuticals Private Limited | Director | 02 Nov 2016 | 9 Years 11 Months | Current |
| Kuldeep Bansal | Director | 02 Nov 2016 | 9 Years 11 Months | Current |
| Jagdeep Bansal Also directs: Bansal Infraprojects Private Limited, Bright Infratech Private Limited, Bansal Infrastructures Private Limited and 5 more | Director | 02 Nov 2016 | 9 Years 11 Months | Current |
Auditor
Riozen Pharmaceutical Private Limited is audited by SUDHIRKUMAR KHANDELWAL for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUDHIRKUMAR KHANDELWAL | FY 2023 | 060486 |
Shareholding
The shareholding of Riozen Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Riozen Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Riozen Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Riozen Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Riozen Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Riozen Pharmaceutical Private Limited, buy the company report.
Recent activity
Riozen Pharmaceutical Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Jagdeep Bansal was appointed as Director on 02 Nov 2016.
Frequently asked questions
Riozen Pharmaceutical is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 November 2016 (10+ years old) and is registered under CIN U74999AP2016PTC104381.
Riozen Pharmaceutical has 4 current directors:
- Smita Samal - Director
- Rajesh Kumar Patra - Director
- Kuldeep Bansal - Director
- Jagdeep Bansal - Director
The latest financial statements of Riozen Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
No. Riozen Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Riozen Pharmaceutical is U74999AP2016PTC104381. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Riozen Pharmaceutical was incorporated on 02 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Vijayawada.
Jagdeep Bansal was appointed as Director on 02 Nov 2016. Kuldeep Bansal was appointed as Director on 02 Nov 2016. Rajesh Kumar Patra was appointed as Director on 02 Nov 2016. Riozen Pharmaceutical has 4 board changes on record in total.
The registered office of Riozen Pharmaceutical is at 1 – 1 – 193 Mvp Colony Sector – 11&12 Indira Nagar Pedawaltair, Visakhapatnam, Andhra Pradesh, India – 530017.
Riozen Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Riozen Pharmaceutical is compliant as of 20 August 2026. The company is actively filing with the Registrar of Companies.